ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,053Medicare Part D Prescriptions Filled, Including Refills

Rank: 264 out of 1000

$253K Total Retail Price of All Prescriptions

Rank: 517 out of 1000

257 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

68% of this provider’s 257 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 6,181 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$25 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
METOPROLOL TARTRATE 754 503 1 19
HYDROCODONE-ACETAMINOPHEN 537 283 S3 2 1
ACETAMINOPHEN-CODEINE 443 227 S3 3 127
MISOPROSTOL 409 261 10 4 278
NAPROXEN 400 279 5 81
OMEPRAZOLE 341 232 6 2
SIMVASTATIN 290 200 7 3
NIFEDIPINE ER 283 180 8 130
FUROSEMIDE 271 174 9 7
CIPROFLOXACIN HCL 271 132 9 46
HYDROCHLOROTHIAZIDE 227 169 11 9
TRIAMTERENE-HCTZ 221 128 12 48
PRAVASTATIN SODIUM 192 128 13 12
CYCLOBENZAPRINE HCL 180 89 R 14 39
POTASSIUM CHLORIDE 176 116 15 10
ENALAPRIL MALEATE 165 108 16 58
HYDRALAZINE HCL 147 101 17 74
IBUPROFEN 145 98 18 94
RANITIDINE HCL 142 62 19 37
CLOPIDOGREL 139 92 20 35
GLIPIZIDE ER 137 61 21 106
ALBUTEROL SULFATE 131 76 22 142
AMLODIPINE BESYLATE 129 92 23 6
DIGOXIN 118 80 24 52
PLAVIX 116 76 25 49
SINGULAIR 107 52 26 84
ALLOPURINOL 106 86 27 31
TRAMADOL HCL 100 36 28 13
METFORMIN HCL 92 64 29 8
DIOVAN 80 58 30 67
MEGESTROL ACETATE 75 53 R 31 134
COLCRYS 74 51 32 171
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 31 33 70
LISINOPRIL 72 49 33 5
METHYLPREDNISOLONE 68 25 35 103
GLIPIZIDE XL 66 45 36 138
WARFARIN SODIUM 66 47 36 22
CAPTOPRIL 66 44 36 260
HUMULIN 70-30 65 25 39 131
KLOR-CON M20 63 28 40 66
ATENOLOL 62 50 41 24
CARVEDILOL 61 61 42 15
INSULIN SYRINGE 59 29 43 93
THEOPHYLLINE ANHYDROUS 57 16 44 186
MONTELUKAST SODIUM 55 23 45 132
AVODART 54 50 46 214
GLIPIZIDE 52 43 47 62
CARISOPRODOL 52 18 R 47 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.